Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2026-01-07 @ 12:01 PM
Study NCT ID:
NCT03285594
Status:
COMPLETED
Last Update Posted:
2021-05-11
First Post:
2017-09-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic Agents
Sponsor:
Lexicon Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-15
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-27
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-14
First Submit QC Date:
None
Study First Post Date:
2017-09-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-04-16
Results First Submit QC Date:
None
Results First Post Date:
2021-05-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-08-20
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-04-16
Last Update Post Date:
2021-05-11
Last Update Post Date Type:
ACTUAL